Feb 25, 2021 / 05:40PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Associate
Okay. Thanks for joining us. My name is Mike Ryskin. I'm one of the Bank of America Life Sciences Tools & Diagnostics team, and we also cover animal health here.
So for our next session, we're joined by Phibro Animal Health. The CEO, Jack Bendheim; CFO, Damian Finio; and Danny Bendheim, who will be covering some of the companion animal business for us. So gentlemen, thank you for joining us.
Jack Clifford Bendheim - Phibro Animal Health Corporation - Chairman, President & CEO
Thank you.
Damian Finio - Phibro Animal Health Corporation - CFO
Good to see you.
Questions and Answers:
Michael Leonidovich Ryskin - BofA Securities, Research Division - AssociateI think to start, maybe we'll just -- we'll kick things off with you, Jack, if you don't mind. You just reported fiscal 2Q results about a week ago. Can you give us just a quick recap of some of the key points from the